{"disease":{"id":"hearth-failure-with-reduced-ejection-fraction-hfref","name":"hearth failure with reduced ejection fraction hfref"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02690974","title":"Description of Tolerability of LCZ696 (Sacubitril / Valsartan) in Heart Failure With Reduced Ejection Fraction (HFrEF) Treated in Real Life Setting","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":302,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT07469137","title":"THE RELATIONSHIP BETWEEN CARDIAC RESYNCHRONİZATION THERAPY RESPONSE IN HEART FAILURE PATIENTS AND YKL-40 LEVELS","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":51,"lead_sponsor_name":"Trakya University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}